A microRNA component of the hypoxic response

Cell Death and Differentiation

Volumn 15, Issue 4, 2008, Pages 667-671

  Kulshreshtha, R ^a   Davuluri, R V ^b   Calin, G A ^c   Ivan, M ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICRO RNA OLIGONUCLEOTIDE; ANTINEOPLASTIC AGENT; GEMCITABINE; HYPOXIA INDUCIBLE FACTOR; LOCKED NUCLEIC ACID; MICRORNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER GENETICS; CARCINOGENESIS; CELL PROLIFERATION; DRUG TARGETING; EVIDENCE BASED MEDICINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC MANIPULATION; HUMAN; HYPOXIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; RNA TRANSLATION; SOLID TUMOR;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICRORNAS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 40949122258     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402310     Document Type: Review

References (39)

1. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signaling. Science 2005; 310: 1288-1289.
2. Miska EA. How microRNAs control cell division, differentiation and death? Curr Opin Genet Dev 2005; 15: 563-568.
3. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-450.
4. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
5. Rana TM. Illuminating the silence: Understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007; 8: 23-36.
6. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801.
7. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
8. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
9. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070.
10. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004; 101: 9740-9744.
11. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 20O5; 435: 834-838.
12. Yanaihara N, Caplen N, Bownan E, Seike M, Kumamoto K, Yi M et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
13. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-843.
14. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007; 282: 2130-2134.
15. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
16. Bacon AL, Harris AL. Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann Med 2004; 36: 530-539.
17. Gruber M, Simon MC. Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr Opin Hematol 2006; 13: 169-174.
18. Km JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177-185.
19. Koumenis C. ER stress, hypoxia tolerance and tumor progression. Curr Mol Med 2006; 6: 55-69.
20. Gordan JD, Simon MC. Hypoxia-inducible factors: Central regulators of the tumor phenotype. Curr Opin Genet Dev 2007; 17: 71-77.
21. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ et al. A microRNA signature of hypoxia. Mol Cell Biol 2007; 27: 1859-1867.
22. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 2006; 1: A116.
23. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007; 6: 5.
24. Donker RB, Mouillet JF, Nelson DM, Sadovsky Y. The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Mol Hum Reprod 2007; 13: 273-279.
25. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966.
26. Zhou X, Ruan J, Wang G, Zhang W. Characterization and identification of miroRNA core promoters in four model species. PLoS Comput Biol 2007; 3: E37.
27. Davuluri RV, Grosse I, Zhang MQ. Computational identification of promoters and first exons in the human genome. Nat Genet 2001; 29: 412-417.
28. Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davaluri RV, Ivan M. Regulation of microRNA expression: The hypoxic component. Cell Cycle 2007; 6: 1426-1431.
29. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
30. Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 2007; 26: 3769-3776.
31. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37 495-500.
32. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
33. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: MicroRNA sequences, targets and gene nomenclature. NAR 2006; 34 (Database issue): D140-D144.
34. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al mIR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 3944-3949.
35. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
36. Weiler J, Hunziker J, Hall J. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Therapy 2006; 13: 496-502.
37. Orom UA, Kauppinen S, Lund AH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006; 372: 137-141.
38. Krutzfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T et al Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007; 35: 2885-2892.
39. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130 2113-2129.